Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
HUGEEE PUMP and DUMP!!!
TOXIC TOXIC TOXIC!!!!
GET READY TO RUMBLE IN THE MUSHROOM JUNGLE!!
So this is frustrating. Anytime we approach a pps of .38 it sells off. Because this is a Canadian company and the Canadian investors are selling off at .50CAD which is .38USD. smh. I kept running into this with MindMed earlier this year and eventually just gave up. We'll need a massive push to get the Canadians to stop selling at their .50 cent level.
i'd be going to all the breakout boards with this if I had the right subscription
All Psychedelic initiatives passed!
Oregon and DC will effectively decriminalise psychedelics for 5 million people following successful ballot initiatives.
— Psychedelic Alpha (@Psyched_Alpha) November 4, 2020
OR Measure 109: Legalises Psilocybin Therapy
OR Measure 110: Decriminalises Drugs
DC Initiative 81: Decriminalises Psychedelics pic.twitter.com/gbeJAi8hhK
https://stockhouse.com/news/newswire/2020/11/03/1st-canadian-pubco-to-complete-legal-harvest-psilocybe-mushrooms
1st Canadian PubCo to “Complete Legal Harvest of Psilocybe Mushrooms”
9 hours ago
In a recent Stockhouse podcast, many of our investor audiences were introduced to a new Company that’s advancing psychedelic laboratory testing, therapy, and research, with an ultimate purpose of delivering the highest quality outcomes to their clients.
Today, Numinus Wellness Inc. (NUMI) (TSX-V.NUMI, OTCMKTS: LKYSF, Forum) is at the scientific forefront of developing safe, evidence-based psychedelic-assisted psychotherapies and other transformative and supportive health solutions. The Company says that it is “creating an ecosystem of health solutions” aimed at advancing psychedelic laboratory testing, therapy, and clinical research.
Also known as ‘magic mushrooms’, psilocybin and psilocybin-assisted psychotherapy are currently being studied as treatments for a wide range of mental health conditions including depression, anxiety, and substance use disorders. NUMI just made a giant leap forward for the entire psychedelic industry.
It's a Canadian stock.
volume is still anemic
Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms
https://numinus.ca/investors/news-release/numinus-first-canadian-public-company-to-complete-legal-harvest-of-psilocybe-mushrooms
Numinus Bioscience's developments include harvesting its first flush of Psilocybe mushrooms at its Health Canada licensed facility.
VANCOUVER, BC, Oct. 22, 2020 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, has harvested the first legal flush of Psilocybe mushrooms in Canada by a public company under its Health Canada-issued Controlled Drugs and Substances Dealer's Licence. This news coincides with other recent developments by Numinus Bioscience, the Company's 7,000 square foot analytics and research laboratory, which is focused on handling various psychedelic substances and developing analytical methods and formulations for the evolving psychedelics space.
Numinus Bioscience first Psilocybe cubensis harvest
Numinus Bioscience first Psilocybe cubensis harvest
Numinus Bioscience Preparation of Harvested mushrooms for freeze drying as the first step to mycochemical discovery and development of standardized testing
Numinus Bioscience Preparation of Harvested mushrooms for freeze drying as the first step to mycochemical discovery and development of standardized testing
Numinus Bioscience Psilocybe mushroom
Numinus Bioscience Psilocybe mushroom
"The first harvest of legally grown Psilocybe mushrooms is a significant milestone for the whole industry" said Michael Tan, Chief Operating Officer. "Now, we can progress with research and development of standardized cultivation, extraction, and testing methods and exploring product formulations to support safe, evidence-based, accessible psychedelic-assisted psychotherapy, as well as build a sequenced spore library."
Dennis McKenna, renowned ethnopharmacologist, Co-founder of the Heffter Research Institute, Founder of the McKenna Academy of Natural Philosophy, and member of Numinus' General Advisory Council, adds, "While there is a place for synthetic psilocybin in clinical practice, well-characterized and standardized extracts of natural forms of psilocybin i.e., mushrooms, cultivated and processed under stringent quality control protocols, are the wave of the future as therapeutic psilocybin gains acceptance. Given a choice, many people would prefer the option to use natural psilocybin. Mushrooms have been used in traditional medicine for literally thousands of years, and hence, they are just that much closer to these ancient traditions. Natural mushroom extracts are also likely to be far more affordable compared to synthetic psilocybin, and that is an important consideration when it comes to ensuring accessibility to this medicine which can be so beneficial to many people. Cost should not be a barrier to access these medicines, and the use of mushroom extracts will help ensure those who need them most can benefit from psilocybin therapies."
Numinus Bioscience is establishing itself at the forefront of analytical testing for psychedelic substances, as a centre of excellence for psychedelic product research and development, and as an ancillary for psychedelic therapy clinical trials. Health Canada licences, scientific expertise, and state-of-the-art technologies facilitate ongoing innovation, while revenue from high-throughput contract cannabis testing is reinvested to further its psychedelic initiatives.
In addition to today's announcement, Numinus includes in its recent developments an amendment application to its Health Canada-issued Controlled Drugs and Substances Licence. The current licence permits testing, import and export, storage and distribution of MDMA, Psilocybin, Psilocin, DMT, and Mescaline as well as the undertaking of novel mycological research initiatives. The amendment will additionally permit the sale of Psilocybe mushroom fruiting bodies and extract for clinical research protocols and the development of standardized testing for additional psychedelic substances.
Numinus is also proud to announce the recent appointment of Sharan Sidhu, regulatory expert and policy advisor for restrictive high growth industries, as Science Officer and General Manager. Sidhu brings extensive experience as a hub between academia, industry, and governing directorates to align research objectives with regulatory compliance. She has been a key strategist for research roadmaps, core initiatives, the development of IP, and the development of compliance requirements including LIMS, GLP/GMP, GACP, and ISO Standards.
"Sharan's experience and leadership are already proving instrumental in establishing Numinus Bioscience as a centre of excellence and major industry player in the delivery of safe, evidence-based, accessible psychedelic-psychotherapy," said Payton Nyquvest, CEO, Founder, and Chairman. "We are honoured to have her join us on our mission."
Sidhu is leading an accomplished scientific research team including Dr Bernd O. Keller, PhD (Advanced Analytical Methods), Dr Kristina Grotzinger, PhD (Phytochemistry), and Judit Varga, MSc (Advanced Microbiology Methods).
biggest and best mushroom play in the market...boom, its gonna be huge!!
We're moving today. Volume is up and first day closing above .28 in 7 sessions.
What about Red Light Holland, I think they are already selling truffles in Netherlands. Sad part is the stock never moves above .07
Agreed whole new market with the Mushrooms.LKYSF
HUGEEE PUMP AND DUMP!!!
Pathway was the first out of the gate with psilocybin research. it's trading on nasdaq at $30 something a share. MIND MEDICINE MINDMED INC.(MMEDF) has just applied to Nasdaq as is exploding. now this one...a new sector seems to be forming
TRIPLE TOXIC RINSE! PUMP and DUMP!
NUMI.CA the first SHROOM GROW OPP...THIS WILL BE HUGE!!
Looking good here and still very quiet..
Psychedelics market poised for huge upside from here imo
Finally we are in cultivation / production. Next step is revenues and pps appreciation will follow and a steady pace
Followers
|
24
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
130
|
Created
|
05/20/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |